Literature DB >> 8869305

Proinflammatory cytokine release by peripheral blood mononuclear cells from patients with acute pancreatitis.

A C de Beaux1, J A Ross, J P Maingay, K C Fearon, D C Carter.   

Abstract

Proinflammatory cytokine release was measured from peripheral blood mononuclear cells (PBMCs) isolated from six volunteers and, on admission, from 16 patients with acute pancreatitis. Tumour necrosis factor (TNF) release in patients did not differ significantly from that of volunteers, whereas both interleukin (IL) 6 and IL-8 release in patients was raised when compared with that in the volunteer group (mean(s.e.m.) IL-6 20.7(4.6) versus 9.3(1.7) ng/ml, P = 0.03; IL-8 283(40) versus 128(22) ng/ml, P = 0.04). When variation in white cell count was accounted for, IL-6 and IL-8 release but not that of TNF was significantly greater in patients with severe disease than in those with mild disease. These results point to a complex upregulation of proinflammatory cytokine release from PBMCs in patients with acute pancreatitis, components of which relate to the clinical progress of the disease.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8869305     DOI: 10.1002/bjs.1800830811

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  18 in total

1.  Current concept of pathogenesis of severe acute pancreatitis.

Authors:  Xie-Ning Wu
Journal:  World J Gastroenterol       Date:  2000-02       Impact factor: 5.742

2.  Therapeutic application of caspase 1/interleukin-1beta-converting enzyme inhibitor decreases the death rate in severe acute experimental pancreatitis.

Authors:  Adam S Paszkowski; Bettina Rau; Jens M Mayer; Peter Möller; Hans G Beger
Journal:  Ann Surg       Date:  2002-01       Impact factor: 12.969

3.  Blood serum levels of proinflammatory cytokines in patients with different degrees of biliary pancreatitis.

Authors:  Józefa Panek; Danuta Karcz; Rrichard Pieton; Jakub Zasada; Marcin Tusinski; Miroslaw Dolecki; Marek Winiarski
Journal:  Can J Gastroenterol       Date:  2006-10       Impact factor: 3.522

4.  alpha,beta-amyrin, a natural triterpenoid ameliorates L-arginine-induced acute pancreatitis in rats.

Authors:  Caroline-Mourão Melo; Karine-Maria-Martins-Bezerra Carvalho; Julliana-Catharina-de-Sousa Neves; Talita-Cavalcante Morais; Vietla-Satyanarayana Rao; Flávia-Almeida Santos; Gerly-Anne-de-Castro Brito; Mariana-Helena Chaves
Journal:  World J Gastroenterol       Date:  2010-09-14       Impact factor: 5.742

5.  Inflammatory mediators in human acute pancreatitis: clinical and pathophysiological implications.

Authors:  J Mayer; B Rau; F Gansauge; H G Beger
Journal:  Gut       Date:  2000-10       Impact factor: 23.059

6.  Clinical observation of immunity for severe acute pancreatitis.

Authors:  ZhiMin Liu; YinFeng Shen; NaiQiang Cui; Jing Yang
Journal:  Inflammation       Date:  2011-10       Impact factor: 4.092

7.  Technetium-99m-labeled white blood cells: a new method to define the local and systemic role of leukocytes in acute experimental pancreatitis.

Authors:  J Werner; S C Dragotakes; C Fernandez-del Castillo; J A Rivera; J Ou; D W Rattner; A J Fischman; A L Warshaw
Journal:  Ann Surg       Date:  1998-01       Impact factor: 12.969

8.  Effects of trimetazidine in acute pancreatitis induced by L-arginine.

Authors:  Akan Yenicerioglu; Ziya Cetinkaya; Mustafa Girgin; Bilal Ustundag; Ibrahim H Ozercan; Refik Ayten; Burhan H Kanat
Journal:  Can J Surg       Date:  2013-06       Impact factor: 2.089

9.  Effect of 5-FU on modulation of disarrangement of immune-associated cytokines in experimental acute pancreatitis.

Authors:  Xiao-Li Chen; Sang-Zhu Ciren; Hui Zhang; Li-Geng Duan; Alexander J Wesley
Journal:  World J Gastroenterol       Date:  2009-04-28       Impact factor: 5.742

10.  Melatonin modulates the severity of taurocholate-induced acute pancreatitis in the rat.

Authors:  Kaptan Gülben; Hakan Ozdemir; Uğur Berberoğlu; Hahan Mersin; Fikret Yrkin; Ebru Cakýr; Sebahat Aksaray
Journal:  Dig Dis Sci       Date:  2009-04-28       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.